Symbio Signs Five-Year Agreement for OmniComm's TrialMaster EDC
July 09, 2019
July 09, 2019
FORT LAUDERDALE, Florida, July 9 -- OmniComm Systems issued the following news release:
Symbio LLC, a client-focused, full-service clinical research organization (CRO), has signed a five-year contract with OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data management technology. Under the agreement, Symbio will use OmniComm's TrialMaster version 5 to develop and manage clinical study databases.
"With TrialMaster, we have the ability to . . .
Symbio LLC, a client-focused, full-service clinical research organization (CRO), has signed a five-year contract with OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data management technology. Under the agreement, Symbio will use OmniComm's TrialMaster version 5 to develop and manage clinical study databases.
"With TrialMaster, we have the ability to . . .